Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 94Unknown 57Terminated 14Active not recruiting 9Withdrawn 6Recruiting 2Approved for marketing 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 182pembrolizumab 157Pemetrexed 132Cisplatin 98Drug Therapy 68Paclitaxel 61osimertinib 55Nivolumab 50Magnetic Resonance Spectroscopy 50Specimen Handling 49durvalumab 48Radiotherapy 48Docetaxel 44atezolizumab 43Etoposide 40Bevacizumab 39tislelizumab 33Blood Specimen Collection 33Radiosurgery 31Gemcitabine 29130-nm albumin-bound paclitaxel 28Immunotherapy 26Immune Checkpoint Inhibitors 24cemiplimab 23Injections 22aflutinib 20Cetuximab 19Biopsy 18Platinum Compounds 17Surgical Procedures, Operative 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Gefitinib × Thoracic × Clear all
NCT06071013 2025-01-23

Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients

China Medical University Hospital

Phase 1/2 Recruiting
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04322890 2024-10-22

PIKACHU

Hunan Province Tumor Hospital

Phase 2 Recruiting
6,000 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡